Skip to main content
Lennart Mucke, MD, Neurology, San Francisco, CA

LennartMuckeMD

Neurology • San Francisco, CA

Director of the Gladstone Institute of Neurological Disease Joseph B. Martin Distinguished Professor of Neuroscience and a Professor of Neurology at the University of California, San Francisco (UCSF)

Join to view full profile

Are you Dr. Mucke?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 37 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1001 Potrero Ave
    San Francisco, CA 94110
    Phone+1 415-206-8492

Summary

  • Dr. Lennart Mucke, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California and Massachusetts. He is affiliated with UCSF Medical Center and is a Director of the Gladstone Institute of Neurological Disease Joseph B. Martin Distinguished Professor of Neuroscience and a Professor of Neurology at the University of California at San Francisco (UCSF).

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1985 - 1989
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationInternship, Internal Medicine, 1984 - 1985
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2026
  • MA State Medical License
    MA State Medical License 1988 - 2001
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • Q&A with Neurological Disease Expert
    Q&A with Neurological Disease ExpertSeptember 10th, 2024
  • Discovery of How Blood Clots Damage the Brain and Body in COVID-19 Points to New Therapy
    Discovery of How Blood Clots Damage the Brain and Body in COVID-19 Points to New TherapyAugust 28th, 2024
  • Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy
    Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New TherapyAugust 28th, 2024
  • Join now to see all

Grant Support

  • Mouse Models With Regulatable Cell Type-Specific Expression Of Anti-Tau ShrnasNational Institute On Aging2011–2012
  • Kinases Linking Abeta And TAU To Synaptic DysfunctionNational Institute Of Neurological Disorders And Stroke2011–2012
  • Behavioral CoreNational Institute Of Neurological Disorders And Stroke2011–2012
  • Potential Role Of Epilepsy In Alzheimer? DiseaseNational Institute On Aging2009–2012
  • Phosphoproteomic Analysis Of Synaptic Proteins In Alzheimer Disease Mouse ModelsNational Center For Research Resources2010–2011
  • Differences In Post-Translational Modification Of TAU In Happ VS Normal MiceNational Center For Research Resources2010–2011
  • Proteinopathies Of The Aging Central Nervous SystemNational Institute On Aging2008–2011
  • Mechanisms Of Ab-Induced Neuronal DeficitsNational Institute On Aging2008–2011
  • Animal CoreNational Institute On Aging2008–2011
  • Administrative CoreNational Institute On Aging2007–2011
  • Transgenic Models To Study Alzheimer'S DiseaseNational Institute On Aging2002–2011
  • Novel Therapeutic Approaches To Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2009–2010
  • Roles Of Amyloid Precursor Protein And Its Metabolites In Neuronal ImpairmentNational Institute Of Neurological Disorders And Stroke2007–2010
  • Phosphoproteomic Analysis Of Synaptic Proteins In Alzheimer'S DiseaseNational Center For Research Resources2009
  • Molecular Indicators Of Dementia Related DeficitsNational Institute On Aging2004–2008
  • Mechanisms Of Amyloid Beta Peptide-Induced Neuronal DeficitsNational Institute On Aging2007
  • Core--AnimalNational Institute On Aging2007
  • Proteopathies Of The Aging Central NervousNational Institute On Aging2004–2007
  • Proteopathies Of The Aging Central Nervous SystemNational Institute On Aging2003–2007
  • Role Of APP And Its Metabolites In Synaptic DegenerationNational Institute Of Neurological Disorders And Stroke2001–2006
  • A Beta Vaccination: Mechanisms And Therapautic ImpactNational Institute Of Neurological Disorders And Stroke2001–2005
  • Transgenic Models To Sudy Alzheimers DiseaseNational Institute On Aging1998–2001
  • Therapeutic Targets In Transgenic MiceNational Institute Of Mental Health1997–2000
  • Molecular Mechanisms Of HIV-1 NeurotoxicityNational Institute Of Mental Health1996–2000
  • Etiologic Factors Of Alzheimer'S Disease And Their Analysis In Transgenic ModelsNational Institute On Aging1996–1998
  • Transgenic Models To Study AIDS Dementia ComplexNational Institute Of Neurological Disorders And Stroke1995–1998
  • In Vivo CNS Effects Of HIV1 Coat Proteins And NefNational Institute Of Neurological Disorders And Stroke1996–1997
  • Transgenic Models To Study Alzheimers DiseaseNational Institute On Aging1996
  • Transgenic Models To Study AIDS Dementia ComplexNational Institute Of Neurological Disorders And Stroke1995
  • In Vivo CNS Effects Of HIV-1 Coat Proteins And NefNational Institute Of Neurological Disorders And Stroke1994–1995
  • Transgenic Models To Study Alzheimers DiseaseNational Institute On Aging1994
  • Transgenic Models To Study Alzheimer'S DiseaseNational Institute On Aging1992–1993

Professional Memberships

Dr. Lennart Mucke, Dr. Lennart Mucke, MD, Dr. L Mucke